Presentations

Papel de las estatinas en el tratamiento intervencionista de los síndromes coronarios agudos

solaci
solaci
392
0

estatinas_tratamiento_sindromes_coronarios_abelardo_lopez
José Abelardo López
2013-02-21

Previous article
A localização da lesão coronária associada ao risco de sangramento pode direcionar a duração da dupla terapia antiplaquetária
Next article
Tratamiento Endovascular de la Estenosis Aortica Experiencia Argentina
solaci
solaci

More articles by this author

Papel del cardiólogo en la revascularización global. Pie diabético

solaci - 0
Francisco Tortoledo 2013-02-21

Problemas con las endoprótesis para aorta torácica

solaci - 0
Esteban Mendaro 2013-02-21

Complicaciones y retos de las endoprótesis abdominales

solaci - 0
Esteban Mendaro 2013-02-21

Prevención Secundaria en el Síndrome Coronario Agudo

solaci - 0
Nohel Castro Blanchard 2013-02-21

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Dr. Juan Manuel Pérez - 0
Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Dr. Juan Manuel Pérez - 0
Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Dr. Juan Manuel Pérez - 0
Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...